Dong Yang
Zhengzhou, 450008, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Systematic prioritization of potential therapeutic targets for glomerulonephritis using multi-omics Mendelian randomization.
Journal: PLoS computational biology
Published: November 08, 2025
Unraveling the molecular landscape and therapeutic strategies for acute kidney injury: insights from transcriptomics, network pharmacology, virtual screening, and in vitro experiments.
Journal: Molecular diversity
Published: June 29, 2025
Recurrence risk prediction for non-muscle-invasive bladder urothelial carcinoma using diffusion and clinicopathology features.
Journal: Abdominal radiology (New York)
Published: April 20, 2025
The Value of Multi-directional High b-Value DWI in the Assessment of Muscular Invasion in Bladder Urothelial Carcinoma: In Comparison with VI-RADS.
Journal: Academic radiology
Published: August 21, 2024
HMMR is a downstream target of FOXM1 in enhancing proliferation and partial epithelial-to-mesenchymal transition of bladder cancer cells.
Journal: Experimental cell research
Published: July 19, 2021
A case report of severe Fusobacterium nucleatum sepsis secondary to nephrectomy.
Journal: BMC infectious diseases
Published: June 23, 2021
Systematic screening of protein-coding gene expression identified HMMR as a potential independent indicator of unfavorable survival in patients with papillary muscle-invasive bladder cancer.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 02, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026